Solasia Pharma KK
TSE:4597
Solasia Pharma KK
Cash from Financing Activities
Solasia Pharma KK
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Solasia Pharma KK
TSE:4597
|
Cash from Financing Activities
¥275m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Cash from Financing Activities
¥10.7B
|
CAGR 3-Years
137%
|
CAGR 5-Years
54%
|
CAGR 10-Years
11%
|
|
PeptiDream Inc
TSE:4587
|
Cash from Financing Activities
¥264.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Cash from Financing Activities
-¥5.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Cash from Financing Activities
-¥535k
|
CAGR 3-Years
33%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
S
|
StemRIM Inc
TSE:4599
|
Cash from Financing Activities
¥202.6m
|
CAGR 3-Years
-70%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
See Also
What is Solasia Pharma KK's Cash from Financing Activities?
Cash from Financing Activities
275m
JPY
Based on the financial report for Dec 31, 2023, Solasia Pharma KK's Cash from Financing Activities amounts to 275m JPY.
What is Solasia Pharma KK's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-39%
Over the last year, the Cash from Financing Activities growth was -89%. The average annual Cash from Financing Activities growth rates for Solasia Pharma KK have been -47% over the past three years , -39% over the past five years .